SCHEMBL30003712

SCHEMBL30003712

O=C1CCCCc2c(Br)cccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.53
PARP11 Q9NR21 1/20 0.53
PIM1 P11309 1/20 0.47
CSNK1A1 P48729 1/20 0.47
CDK5 Q00535 1/20 0.47
ROCK1 Q13464 1/20 0.47
DYRK1A Q13627 1/20 0.47
LRRK2 Q5S007 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
DYRK1B Q9Y463 1/20 0.47
KDM4E B2RXH2 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP2A6 P11509 1/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
BRD4 O60885 1/20 0.36
ADRB2 P07550 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7920173 1.00 PARP10 (0.53) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL1661783 0.96 PARP10 (0.53) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL29514736 0.96 PARP10 (0.53) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL28004728 0.89 PARP10 (0.47) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL29429928 0.88 PARP10 (0.56) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL163925 0.88 PARP10 (0.56) PARP10PARP11PIM1CSNK1A1CDK5
Methylamine SCHEMBL27811293 0.82 PARP10 (0.51) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL28041457 0.79 MAOA (0.56) KDM4EHSD17B10CYP2A6MAOAMAOB
SCHEMBL5752790 0.78 PARP1 (0.55) PARP10PARP11KDM4ECYP2A6MAOA
SCHEMBL7052870 0.77 PARP10 (0.58) PARP10PARP11PIM1CSNK1A1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022218311-A1 MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF APPICINE THERAPEUTICS (HK) LIMITED (CN) 2022-10-20 WO disclosed